Title: Activation of glycogen synthase kinase-3beta is required for hyperdopamine and d2 receptor-mediated inhibition of synaptic nmda receptor function in the rat prefrontal cortex.
Summary: GSK-3beta is required for the hyperdopamine/D2 receptor-mediated inhibition of NMDA receptors in the prefrontal neurons and these actions may underlie D2 receptor-mediated psychostimulant effects and hyperdopamine-dependent behaviors in the brain.
Li, Y.-C., Xi, D., Roman, J., Huang, Y.-Q., and Gao, W.-J. (2009). Activation of glycogen synthase kinase-3beta is required for hyperdopamine and d2 receptor-mediated inhibition of synaptic nmda receptor function in the rat prefrontal cortex. 29(49):15551-15563. http://www.citeulike.org/user/HEIRS/article/6347607
Cuadrado, A., Moreno-Murciano, P., and Pedraza-Chaverri, J. (2009). The transcription factor nrf2 as a new therapeutic target in parkinson's disease. Expert Opinion on Therapeutic Targets, 13(3):319-329. http://www.citeulike.org/user/HEIRS/article/4116731
HEIRS Health & Home
www.heirs-online.com
heirshealth@gmail.com
Check out some of our cool, more eco-friendly, non-toxic or got-to-have items in the HEIRS Web Store at Amazon or specialty items in our store at HEIRS Store Online.
No comments:
Post a Comment